Programme (PDF) - (NCRI) Cancer Conference 2013 - National ...

Parallel sessions in detail Wednesday
Brain tumours
Hosted by Susan Short
University College Hospital, London, UK
o Susan Short
University College Hospital, London, UK
Introduction
o Rossella Galli
Stem cell Research Institute, Milan, Italy
Functional and molecular characterisation of cancer stem cells
from brain tumours
o Walter Stummer
University of Dusseldorf, Germany
Issues in the surgical therapy of malignant gliomas
o Anca Grosu
University of Freiburg, Germany
PET imaging and glioma
Proffered paper presentations:
o Talal Fael Al-Mayhani
University of Cambridge, UK
NG2 expression identifies a cell population capable of
maintaining tumour growth in glioblastoma
o Simone Wilkins
University of Liverpool, UK
Vascularity in regions of highest choline predicts progression in
low grade astrocytomas
o Mausam Singhera
University College London, UK
Outcome in a 2-year cohort of brain metastases patients
treated in a specialist multi-disciplinary clinic at UCLH
Economics of drug development and provision
Hosted by Sir Kenneth Calman 1 and David Ardron 2
1 2 University of Glasgow, UK; and NCRI Consumer Liaison Group
o Sir Kenneth Calman 1 and David Ardron 2
1 University of Glasgow, UK; and 2 NCRI Consumer Liaison Group, UK
Introduction
o Alison Clough
The Association of the British Pharmaceutical Industry, London, UK
Life and medicines: price and value
o Elisabeth George
National Institute for Health and Clinical Excellence, London, UK
Appraising cancer drugs at the National Institute for Clinical and
Health Excellence
o David Gillen
Pfizer, UK
The challenge for the pharmaceutical industry in the 21st century:
discovery, development and access to medicines in a distrustful
environment
o Martin Gore
The Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK
Title to be confirmed
27